Profile data is unavailable for this security.
About the company
VBI Vaccines Inc. is a commercial stage biopharmaceutical company. Through its approach to virus-like particles (VLPs), including an enveloped VLP (eVLP) platform technology, The Company develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. The Company is focused on targeting and overcoming infectious diseases, including hepatitis B (HBV), COVID-19, and coronaviruses, and cytomegalovirus (CMV), as well as cancers, including glioblastoma (GBM). Its product pipeline includes an approved vaccine and multiple late- and early-stage investigational programs. PreHevbrio is its approved vaccine for hepatitis B. Its Prophylactic Candidates for corona virus disease include VBI-2901, VBI-2905, VBI-2902, and other. VBI-1501 is its Prophylactic Candidate for cytomegalovirus. VBI-2501 is its Prophylactic Candidate for Zika virus. VBI-2601 and VBI-1901 are the therapeutic candidates for HBV and GBM.
- Revenue in USD (TTM)8.68m
- Net income in USD-93.84m
- Incorporated2016
- Employees131.00
- LocationVBI Vaccines Inc160 Second Street, CambridgeCAMBRIDGE 02142United StatesUSA
- Phone+1 (617) 830-3031
- Fax+972 8948-0660
- Websitehttps://www.vbivaccines.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Protext Mobility Inc | 750.00 | -2.21m | 15.82m | 4.00 | -- | -- | -- | 21,098.93 | -0.4692 | -0.4692 | 0.00001 | -0.0102 | 0.0405 | -- | -- | -- | -9,400.97 | -1,587.94 | -- | -- | 86.67 | -530.19 | -232,392.00 | -17,498.83 | 0.0002 | -1.36 | -- | -- | -93.98 | -63.09 | 27.35 | -- | -- | -- |
| NanoString Technologies Inc | 162.47m | -166.43m | 16.12m | 703.00 | -- | -- | -- | 0.0992 | -3.53 | -3.53 | 3.44 | -1.05 | 0.4936 | 2.07 | 4.30 | 231,113.80 | -50.56 | -30.01 | -62.82 | -34.66 | 35.72 | 57.14 | -102.44 | -80.87 | 2.02 | -70.17 | 1.29 | -- | -12.28 | 2.06 | -38.43 | -- | 40.03 | -- |
| Cardio Diagnostics Holdings Inc | 17.07k | -8.38m | 16.17m | 7.00 | -- | 5.20 | -- | 947.38 | -0.7363 | -0.7363 | 0.0014 | 0.144 | 0.0032 | -- | 6.88 | 2,438.57 | -156.40 | -- | -211.46 | -- | -- | -- | -49,073.46 | -- | -- | -5.45 | 0.1122 | -- | 1,696.84 | -- | -79.72 | -- | -- | -- |
| Biomx Inc | 0.00 | -26.17m | 16.30m | 58.00 | -- | 4.40 | -- | -- | -0.5433 | -0.5433 | 0.00 | 0.067 | 0.00 | -- | -- | 0.00 | -74.18 | -- | -101.74 | -- | -- | -- | -- | -- | -- | -21.95 | 0.7841 | -- | -- | -- | 7.59 | -- | -- | -- |
| Dominari Holdings Inc | 2.04m | -22.88m | 16.38m | 26.00 | -- | 0.3095 | -- | 8.03 | -4.44 | -4.44 | 0.3899 | 8.92 | 0.0305 | -- | 0.3829 | 78,423.08 | -34.20 | -26.82 | -35.10 | -27.45 | -- | -- | -1,122.22 | -3,353.52 | -- | -- | 0.00 | -- | -- | 135.75 | 12.72 | -- | 63.99 | -- |
| Talis Biomedical Corp | 2.20m | -75.48m | 16.40m | 102.00 | -- | 0.2008 | -- | 7.47 | -41.90 | -41.90 | 1.22 | 44.83 | 0.0146 | -- | 10.03 | 21,529.41 | -50.10 | -- | -53.63 | -- | -7.70 | -- | -3,436.98 | -- | -- | -- | 0.00 | -- | -41.27 | -- | 41.15 | -- | -- | -- |
| Traws Pharma Inc | 226.00k | -18.95m | 16.98m | 16.00 | -- | 1.32 | -- | 75.12 | -0.9029 | -0.9029 | 0.0108 | 0.5081 | 0.0073 | -- | 9.62 | 14,125.00 | -61.07 | -63.43 | -84.61 | -85.72 | -- | -- | -8,384.07 | -3,257.92 | -- | -- | 0.00 | -- | 0.00 | -28.72 | 0.0844 | -- | -- | -- |
| VBI Vaccines Inc | 8.68m | -93.84m | 17.14m | 131.00 | -- | 1.92 | -- | 1.97 | -9.42 | -9.42 | 0.5588 | 0.3147 | 0.0717 | 1.66 | 184.72 | 66,274.81 | -76.71 | -46.58 | -143.53 | -58.62 | -44.09 | -277.46 | -1,069.29 | -2,755.98 | 0.3662 | -4.28 | 0.8709 | -- | 702.40 | 20.94 | 17.18 | -- | -32.07 | -- |
| Benitec Biopharma Inc | 61.00k | -21.81m | 17.42m | 18.00 | -- | 1.13 | -- | 285.59 | -10.90 | -10.90 | 0.0304 | 5.97 | 0.0037 | -- | 1.01 | 3,388.89 | -131.16 | -83.43 | -174.32 | -98.77 | 172.13 | 96.86 | -35,754.10 | -468.04 | -- | -5,423.00 | 0.00 | -- | 2.74 | -53.84 | -7.44 | -- | -56.51 | -- |
| Alaunos Therapeutics Inc | 5.00k | -35.14m | 17.45m | 1.00 | -- | 2.77 | -- | 3,490.72 | -2.20 | -2.20 | 0.0003 | 0.3939 | 0.0001 | -- | 2.00 | 5,000.00 | -96.01 | -74.83 | -149.28 | -89.57 | -- | -- | -702,800.00 | -10,508.06 | -- | -14.83 | 0.00 | -- | -99.83 | -49.08 | 6.86 | -- | -15.56 | -- |
| Flora Growth Corp | 76.07m | -47.36m | 17.52m | 97.00 | -- | 2.29 | -- | 0.2304 | -6.62 | -7.97 | 10.04 | 0.7167 | 1.45 | 6.76 | 31.13 | 784,237.10 | -89.22 | -- | -130.91 | -- | 23.32 | -- | -61.35 | -- | 0.7897 | -- | 0.2317 | -- | 127.75 | -- | -1.87 | -- | -- | -- |
| KALA BIO Inc | 0.00 | -42.20m | 17.83m | 43.00 | -- | 2.33 | -- | -- | -17.94 | -17.94 | 0.00 | 2.72 | 0.00 | -- | -- | 0.00 | -59.12 | -57.83 | -77.62 | -69.32 | -- | 57.06 | -- | -1,553.61 | -- | -12.78 | 0.82 | -- | -100.00 | -- | 5.85 | -- | -17.31 | -- |
| Minerva Neurosciences Inc | 0.00 | -30.01m | 17.83m | 9.00 | -- | -- | -- | -- | -4.65 | -4.65 | 0.00 | -4.07 | 0.00 | -- | -- | 0.00 | -53.59 | -49.89 | -55.94 | -52.39 | -- | -- | -- | -442.65 | -- | -- | -- | -- | -- | -- | 6.55 | -- | -- | -- |
| Solarwindow Technologies Inc | 0.00 | -2.36m | 18.35m | 1.00 | -- | 2.84 | -- | -- | -0.0443 | -0.0468 | 0.00 | 0.1214 | 0.00 | -- | -- | 0.00 | -25.51 | -44.62 | -26.29 | -45.23 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 44.04 | -- | -- | -- |
| Galecto Inc | 0.00 | -38.35m | 18.46m | 13.00 | -- | 0.5711 | -- | -- | -1.45 | -1.45 | 0.00 | 1.19 | 0.00 | -- | -- | 0.00 | -68.84 | -48.46 | -81.18 | -52.36 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 37.77 | -- | -- | -- |
| Allied Corp | 21.51k | -10.20m | 18.48m | -- | -- | -- | -- | 859.18 | -0.1046 | -0.1046 | 0.0002 | -0.0712 | 0.0054 | 2.10 | 0.1673 | -- | -258.20 | -- | -- | -- | -6,919.57 | -- | -47,432.82 | -- | 0.0234 | -36.24 | -- | -- | -56.46 | -- | 31.30 | -- | -- | -- |
Data as of Apr 22 2024. Currency figures normalised to VBI Vaccines Inc's reporting currency: US Dollar USD
11.04%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Perceptive Advisors LLCas of 16 Apr 2024 | 1.26m | 5.33% |
| Alyeska Investment Group LPas of 31 Dec 2023 | 626.44k | 2.65% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 184.44k | 0.78% |
| Geode Capital Management LLCas of 31 Dec 2023 | 138.73k | 0.59% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 111.81k | 0.47% |
| Cambridge Investment Research Advisors, Inc.as of 31 Dec 2023 | 88.39k | 0.37% |
| Citadel Securities LLCas of 31 Dec 2023 | 72.45k | 0.31% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 66.84k | 0.28% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 2023 | 32.99k | 0.14% |
| Morgan Stanley & Co. LLCas of 31 Dec 2023 | 31.71k | 0.13% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
